{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:22:36Z","timestamp":1782519756463,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T00:00:00Z","timestamp":1516665600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00296-018-3929-0","type":"journal-article","created":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T07:32:13Z","timestamp":1516692733000},"page":"461-466","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Variability of Denosumab densitometric response in postmenopausal osteoporosis"],"prefix":"10.1007","volume":"38","author":[{"given":"M.","family":"Laroche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Baradat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ruyssen-Witrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Degboe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,23]]},"reference":[{"key":"3929_CR1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","volume":"354","author":"MR McClung","year":"2006","unstructured":"McClung MR et al (2006) Denosumab in postmenopausal women with low bone mineral density. N Engl J Med 354:821\u2013831","journal-title":"N Engl J Med"},{"key":"3929_CR2","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1359\/jbmr.070809","volume":"22","author":"EM Lewiecki","year":"2007","unstructured":"Lewiecki EM et al (2007) Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD. J Bone Miner Res 22:1832\u20131841","journal-title":"J Bone Miner Res"},{"key":"3929_CR3","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756\u2013765","journal-title":"N Engl J Med"},{"key":"3929_CR4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1210\/jc.2010-1805","volume":"96","author":"PD Miller","year":"2011","unstructured":"Miller PD et al (2011) Effect of denosumab on bone mineral density and biochemical markers of bone turnover: six-year results of a phase 2 clinical trial. J Clin Endocrinol Metab 96:394\u2013402","journal-title":"J Clin Endocrinol Metab"},{"key":"3929_CR5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00198-012-2052-4","volume":"24","author":"MR McClung","year":"2013","unstructured":"McClung MR et al (2013) Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial. Osteoporos Int 24:227\u2013235","journal-title":"Osteoporos Int"},{"issue":"Suppl 1","key":"3929_CR6","first-page":"S471","volume":"30","author":"HG Bone","year":"2015","unstructured":"Bone HG, Brandi ML, Brown JP, Chapurlat R, Cummings SR, Czerwinski E, Fahrleitner-Pammer A, Kendler DL, Lippuner K, Reginster JY, Roux C, Vittinghoff E, Daizadeh NS, Wang A, Dakin P, Wagman RB, Papapoulos S (2015) Ten years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension Trial. J Bone Miner Res (ASBMR Annual Meeting Abstracts) 30(Suppl 1):S471","journal-title":"J Bone Miner Res (ASBMR Annual Meeting Abstracts)"},{"key":"3929_CR7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/jbmr.1472","volume":"27","author":"M Austin","year":"2012","unstructured":"Austin M et al (2012) Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures. J Bone Miner Res 27:687\u2013693","journal-title":"J Bone Miner Res"},{"key":"3929_CR8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1359\/jbmr.090716","volume":"25","author":"DL Kendler","year":"2010","unstructured":"Kendler DL et al (2010) Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy. J Bone Miner Res 25:72\u201381","journal-title":"J Bone Miner Res"},{"key":"3929_CR9","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/AOG.0b013e318291718c","volume":"121","author":"C Recknor","year":"2013","unstructured":"Recknor C et al (2013) Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: a randomized open-label trial. Obstet Gynecol 121:1291\u20131299","journal-title":"Obstet Gynecol"},{"key":"3929_CR10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bone.2013.10.006","volume":"58","author":"C Roux","year":"2014","unstructured":"Roux C et al (2014) Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study. Bone 58:48\u201354","journal-title":"Bone"},{"issue":"8","key":"3929_CR11","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1210\/jc.2016-1801","volume":"101","author":"PD Miller","year":"2016","unstructured":"Miller PD, Pannacciulli N, Brown JP, Czerwinski E, Nedergaard BS, Bolognese MA, Malouf J, Bone HG, Reginster JY, Singer A, Wang C, Wagman RB, Cummings SR (2016) Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates. J Clin Endocrinol Metab 101(8):3163\u20133170","journal-title":"J Clin Endocrinol Metab"},{"key":"3929_CR12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jbspin.2004.07.003","volume":"72","author":"C Roux","year":"2005","unstructured":"Roux C et al (2005) Recommendations for monitoring antiresorptive therapies in postmenopausal osteoporosis. Jt Bone Spine 72:26\u201331","journal-title":"Jt Bone Spine"},{"key":"3929_CR13","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1359\/jbmr.1999.14.8.1449","volume":"14","author":"P Ravaud","year":"1999","unstructured":"Ravaud P et al (1999) Individual smallest detectable difference in bone mineral density measurements. J Bone Miner Res 14:1449\u20131456","journal-title":"J Bone Miner Res"},{"key":"3929_CR14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1359\/jbmr.0809010","volume":"24","author":"JP Brown","year":"2009","unstructured":"Brown JP (2009) Comparison of the effect of Denosumab and Alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass. J Bone Miner Res 24:153\u2013161","journal-title":"J Bone Miner Res"},{"key":"3929_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-015-0731-x","author":"K Ebina","year":"2016","unstructured":"Ebina K et al (2016) The effects of switching daily teriparatide to oral bisphosphonates or denosumab in patients with primary osteoporosis. J Bone Miner Metab. https:\/\/doi.org\/10.1007\/s00774-015-0731-x","journal-title":"J Bone Miner Metab"},{"key":"3929_CR16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.clinthera.2008.03.008","volume":"30","author":"AI Sebba","year":"2008","unstructured":"Sebba AI (2008) Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment. Clin Therapeutics 30:443\u2013451","journal-title":"Clin Therapeutics"},{"key":"3929_CR17","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1210\/jc.2008-1122","volume":"94","author":"SAM Burnett-Bowie","year":"2009","unstructured":"Burnett-Bowie SAM (2009) Prediction of changes in bone mineral density in post menopausal women treated with one-weekly bisphosphonates. J Clin Endocrinol Metab 94:1097\u20131103","journal-title":"J Clin Endocrinol Metab"},{"key":"3929_CR18","first-page":"570","volume":"30","author":"R Eastell","year":"2015","unstructured":"Eastell R (2015) Relationship between pretreatment rate of bone loss and bone density responce to once yearly Zoledronate.J Bone Miner. Res 30:570\u2013574","journal-title":"Res"},{"key":"3929_CR19","doi-asserted-by":"crossref","unstructured":"Ominsky MS, Libanati C, Niu Q, Boyce RW, Kostenuik PJ, Wagman RB, Baron R, Dempster DW (2015) Sustained modeling-based bone formation during adulthood in Cynomolgus monkeys may contribute to continuous BMD gain with denosumab. J Bone Miner Res 7:1280\u20131289","DOI":"10.1002\/jbmr.2480"},{"key":"3929_CR20","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1002\/jbmr.149","volume":"25","author":"IR Reid","year":"2010","unstructured":"Reid IR et al (2010) Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies. J Bone Miner Res 25:2256\u20132265","journal-title":"J Bone Miner Res"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-018-3929-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-3929-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-3929-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T05:40:59Z","timestamp":1519191659000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-018-3929-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,23]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["3929"],"URL":"https:\/\/doi.org\/10.1007\/s00296-018-3929-0","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,23]]}}}